• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global health

    Global Fund is facing ‘colliding crises’ when tackling HIV, TB, malaria

    The Global Fund has saved 65 million lives since its founding in 2002. But Executive Director Peter Sands said the communities they help are now being hit by climate change, conflicts, and attacks on gender and human rights.

    By Jenny Lei Ravelo // 19 September 2024

    Global Fund Executive Director Peter Sands touted the organization’s efforts in 2023 to save millions of lives from HIV, TB, and malaria. But he said the work has become more challenging in the face of “colliding crises.”

    The Global Fund to Fight AIDS, Tuberculosis and Malaria has saved 65 million lives since its founding in 2002, with the combined death rate for the three diseases slashed by 61%, according to its latest Results Report.

    The report shows that the organization’s HIV investments over the last two decades have freed up 1.66 billion HIV-related hospitalization days, and averted 1.36 billion outpatient visits, which according to the fund translates to $85 billion in cost savings. The Global Fund also invested $1.8 billion to strengthen health and community systems in 2023 — the highest amount in a given year — and plans to invest $6 billion between 2024 and 2026.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Funding
    • Global Health
    • The Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM)
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jenny Lei Ravelo

      Jenny Lei Ravelo@JennyLeiRavelo

      Jenny Lei Ravelo is a Devex Senior Reporter based in Manila. She covers global health, with a particular focus on the World Health Organization, and other development and humanitarian aid trends in Asia Pacific. Prior to Devex, she wrote for ABS-CBN, one of the largest broadcasting networks in the Philippines, and was a copy editor for various international scientific journals. She received her journalism degree from the University of Santo Tomas.

    Search for articles

    Related Stories

    MalariaIs the world on track to eradicate malaria?

    Is the world on track to eradicate malaria?

    Global HealthUS aid cuts overshadow HIV research advances

    US aid cuts overshadow HIV research advances

    Global HealthFDA approves new HIV prevention tool, though access questions linger

    FDA approves new HIV prevention tool, though access questions linger

    Global HealthPEPFAR at crossroads: Lawmakers debate future of global HIV program

    PEPFAR at crossroads: Lawmakers debate future of global HIV program

    Most Read

    • 1
      Opinion: How climate philanthropy can solve its innovation challenge
    • 2
      The legal case threatening to upend philanthropy's DEI efforts
    • 3
      Why most of the UK's aid budget rise cannot be spent on frontline aid
    • 4
      How is China's foreign aid changing?
    • 5
      2024 US foreign affairs funding bill a 'slow-motion gut punch'
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement